Stay updated with breaking news from Science Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India will treat a domestic COVID-19 vaccine "equally" with a prominent global one, even though the homegrown drug's efficacy has not been proven, and people will have no choice which they one they get, a top government vaccine official told Reuters.
AIPSN Demands DCGI Reconsider Approvals for Covaxin and Covishield 06/01/2021 A medic demonstrates the administration of Covaxin with a health worker during a dry run in Srinagar, January 2, 2021. Photo: PTI. The Drug Controller General of India’s (DCGI) decision to approve Serum Institute’s Covishield and Bharat Biotech’s Covaxin v vaccine candidates has provoked a firestorm of criticism in the scientific and medical communities. Following this, the All India People’s Science Network published a statement demanding that the DCGI reconsider the approvals, particularly to b...
All-India scientists' network seeks re-consideration of vaccine approval Top Searches: Representative Image. (Reuters Photo) MUMBAI: A national network of 40 science movements, the All-India People’s Science Network (AIPSN), has criticized the central government’s hasty regulatory approvals for the Covid-19 vaccines, particularly for Covaxin developed by the Bharat Biotech. In an open statement the network has sought re-consideration of the approval for Covaxin, till the efficacy data is available. The scientists claimed that ‘the government has shot itself in the foot’ by hastily app...
Criticism of India's approval of a local COVID-19 vaccine without proof of its efficacy grew on Wednesday after news that a regulatory panel ...
Criticism of India's approval of a local COVID-19 vaccine without proof of its efficacy grew on Wednesday after news that a regulatory panel approved the shot just one day after asking the vaccine maker for more evidence it would work.